Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials. [electronic resource]
Producer: 20111207Description: 1498-506 p. digitalISSN:- 1460-2105
- Adult
- Black or African American -- statistics & numerical data
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Chemotherapy, Adjuvant
- Clinical Trials, Phase III as Topic
- Colonic Neoplasms -- drug therapy
- Confounding Factors, Epidemiologic
- Disease-Free Survival
- Female
- Fluorouracil -- administration & dosage
- Health Status Disparities
- Healthcare Disparities
- Humans
- Kaplan-Meier Estimate
- Leucovorin -- administration & dosage
- Levamisole -- administration & dosage
- Lomustine -- administration & dosage
- Male
- Middle Aged
- Multivariate Analysis
- Neoplasm Staging
- Odds Ratio
- Proportional Hazards Models
- Randomized Controlled Trials as Topic
- Treatment Outcome
- United States -- epidemiology
- Vincristine -- administration & dosage
- White People -- statistics & numerical data
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.